PETALING JAYA: The development of the drug Ravidasvir to treat Hepatitis C (HCV) marks a new era in drug discovery, says Tan Sri Dr Noor Hisham Abdullah.
Malaysia registers first hepatitis C treatment developed through South-South cooperation eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Conditional registration for Ravindasvir 200mg tablet for Hepatitis C treatment 04 Jun 2021 / 15:02 H. -Pix for representational purpose only.
KUALA LUMPUR: The Ministry of Health (MOH) would like to inform that the Drug Control Authority (DCA) Malaysia has granted a conditional registration for Ravida® Tablet 200mg (Ravidasvir Hydrochloride 200mg) in their 358th meeting on 4th June 2021. Malaysia is the first country in the world to approve the use of Ravida®, which is indicated in combination with other medicinal products for the treatment of chronic hepatitis C virus (HCV) infection in adults. The product is manufactured by the Doppel Farmaceutici S.R.L, Italy with Pharmaniaga Manufacturing Berhad as the product registration holder in Malaysia.
KUALA LUMPUR: The Drug Control Authority (DCA) Malaysia has granted conditional registration for Ravida® Tablet 200 milligram (Ravidasvir Hydrochlorid.
Africa s need for more COVID-19 clinical trials thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.